Pain News and Research

Latest Pain News and Research

St. Louis College of Pharmacy's Amy Tiemeier suggests four easy resolutions for a healthier 2014

With the new year quickly approaching, many are beginning to think about resolutions. Amy Tiemeier, Pharm.D., BCPS, associate professor of pharmacy practice at St. Louis College of Pharmacy suggests four easy resolutions for a healthier 2014.

18 Dec 2013

FDA accepts Regeneron's EYLEA Injection sBLA for standard review

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted for standard review the Company's supplemental Biologics License Application for EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema.

18 Dec 2013

Chronic pain amongst different ethnic groups: an interview with Professor Martin Underwood, Warwick Medical School

Conventionally chronic pain is defined as pain that lasts beyond the expected period of healing. Most experts consider a pain to be chronic after three months.

18 Dec 2013

Research examines link between opioid suppression of immune system and cancer recurrence

18 Dec 2013

Researchers identify new technique to reduce postoperative pain in children

...

18 Dec 2013

Chemists able to trace narcotics substances, prescription drugs in Swedish wastewater

Chemists at Ume- University in Sweden have been able to trace narcotics substances and prescription drugs in measurements of wastewater from 33 Swedish sewage treatment plants. Cocaine, amphetamine, and methamphetamine, in measurable concentrations, were found in a total of half of the locations.

17 Dec 2013

Navidea seeks FDA approval for marketing Lymphoseek Injection for SLN detection

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that it has submitted a Supplemental New Drug Application with the U.S. Food and Drug Administration seeking approval for the marketing and sale of Lymphoseek (technetium 99m tilmanocept) Injection for sentinel lymph node detection in patients with head and neck cancer, an indication for which Lymphoseek was also granted Fast Track designation earlier this month.

17 Dec 2013

Emergency Nurses Association introduces NEW Geriatric eLearning Course for Nurses

The Emergency Nurses Association announced today the launch of its NEW online Geriatric Emergency Nursing Education Course—GENE.

17 Dec 2013

Researchers use ATX-Red AR-2 as new imaging agent to illuminate tumors

Researchers from Echelon Biosciences, Inc. and collaborators from the University of Utah report the use of ATX-Red AR-2 as a new imaging agent that effectively illuminates tumors.

17 Dec 2013

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Amneal Pharmaceuticals LLC today announced the launch of its branded Esomeprazole Strontium 49.3 mg delayed-release capsules. Esomeprazole Strontium contains the same active moiety (esomeprazole) in a different salt form as found in the branded proton-pump inhibitor Nexium (esomeprazole magnesium) and is a new option for adult patients for the short term treatment of gastroesophageal reflux disease.

17 Dec 2013

Ipsen reports positive initial results from Dysport phase III study in Adult Upper Limb spasticity

Ipsen today announced positive initial results from the double-blind phase III study of Dysport (abobotulinumtoxinA) in Adult Upper Limb spasticity. Regarding the primary endpoints, treatment with Dysport showed statistically significant response versus placebo in the improvement of muscle tone, as measured by the Modified Ashworth Scale.

17 Dec 2013

Research finds link between opioid-sparing technique and reduced progression of prostate cancer

The methods used to anesthetize prostate cancer patients and control pain when their prostate glands are surgically removed for adenocarcinoma may affect their long-term cancer outcomes, a study led by Mayo Clinic has found. Opioids, painkillers commonly given during and after surgery, may suppress the immune system's ability to fight cancer cells.

17 Dec 2013

Utah researchers discover naturally occurring genetic variation that cause inflammatory arthritis

University of Utah researchers have discovered a naturally occurring genetic variation in mice that predisposes carriers toward developing severe, inflammatory arthritis. The finding implicates a new class of genes in arthritis progression, potentially opening doors to new treatment options.

17 Dec 2013

Congressional lawmakers and political opponents stake out health law positions, strategies

Republican primary candidates are caught in an Obamacare fix. Even the slightest hint that a GOP contender might support anything besides all-out repeal of the health care law is drawing attacks from the right. So, increasingly, in races across the country, proposals to fix the existing law or retain any of it are being ruled out by Republicans eager to further burnish their conservative credentials (Hohmann and Cheney, 12/15).

17 Dec 2013

Scientists continue work to end chemotherapy pain

With this year's $600,000 grant from the Leukemia & Lymphoma Society and $1.5 million grant from the NIH, a Saint Louis University investigator is continuing her work to end chemotherapy pain. Noted pain researcher Daniela Salvemini, Ph.D., is using the funding to capitalize on her recent finding published in Pain, a breakthrough that helps scientists understand a molecular pathway by which pain occurs with certain anti-cancer drugs.

17 Dec 2013

NYSE publicly traded industry selects EPGL's advanced technologies for development

EP Global Communications, Inc., makes the following announcement: In a first for the company, one of EPGL's advanced technologies has been selected by a multi-billion dollar, NYSE publicly traded industry leader for development and integration into new products.

16 Dec 2013

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.

16 Dec 2013

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in the EU, today announced that its partner Auxilium Pharmaceuticals, Inc. has dosed the first patient in its Phase 2b study of collagenase clostridium histolyticum for the treatment of frozen shoulder syndrome (adhesive capsulitis).

16 Dec 2013

Duke research team develops better recipe for synthetic replacement cartilage in joints

A Duke research team has developed a better recipe for synthetic replacement cartilage in joints.

16 Dec 2013

Prescription drug misuse and driving after using drugs on the rise among Ontario students

Alcohol consumption and smoking among Ontario students in grades 7-12 is at an all-time low; however recreational use of over-the-counter drugs is on the rise. Prescription drug misuse and driving after using drugs also remain elevated according to the 2013 Ontario Student Drug Use and Health Survey released by the Centre for Addiction and Mental Health.

16 Dec 2013

Pain News and Research

Latest Pain News and Research

St. Louis College of Pharmacy's Amy Tiemeier suggests four easy resolutions for a healthier 2014

FDA accepts Regeneron's EYLEA Injection sBLA for standard review

Chronic pain amongst different ethnic groups: an interview with Professor Martin Underwood, Warwick Medical School

Research examines link between opioid suppression of immune system and cancer recurrence

Researchers identify new technique to reduce postoperative pain in children

Chemists able to trace narcotics substances, prescription drugs in Swedish wastewater

Navidea seeks FDA approval for marketing Lymphoseek Injection for SLN detection

Emergency Nurses Association introduces NEW Geriatric eLearning Course for Nurses

Researchers use ATX-Red AR-2 as new imaging agent to illuminate tumors

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Ipsen reports positive initial results from Dysport phase III study in Adult Upper Limb spasticity

Research finds link between opioid-sparing technique and reduced progression of prostate cancer

Utah researchers discover naturally occurring genetic variation that cause inflammatory arthritis

Congressional lawmakers and political opponents stake out health law positions, strategies

Scientists continue work to end chemotherapy pain

NYSE publicly traded industry selects EPGL's advanced technologies for development

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

Duke research team develops better recipe for synthetic replacement cartilage in joints

Prescription drug misuse and driving after using drugs on the rise among Ontario students

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Pain News and Research

Latest Pain News and Research

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Newsletters you may be interested in